Cargando…
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
Cardiac cells, like those of the other tissues, undergo regulation through membrane-bound proteins known as G protein-coupled receptors (GPCRs). β-adrenergic receptors (βARs) are key GPCRs expressed on cardiomyocytes and their role is crucial in cardiac physiology since they regulate inotropic and c...
Autores principales: | Cannavo, Alessandro, Liccardo, Daniela, Koch, Walter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783981/ https://www.ncbi.nlm.nih.gov/pubmed/24133451 http://dx.doi.org/10.3389/fphys.2013.00264 |
Ejemplares similares
-
GRK2 blockade with βARKct is essential for cardiac β(2)-adrenergic receptor signaling towards increased contractility
por: Salazar, Norma C, et al.
Publicado: (2013) -
Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases
por: Liccardo, Daniela, et al.
Publicado: (2022) -
Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017) -
Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels
por: Marzano, Federica, et al.
Publicado: (2022) -
New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
por: de Lucia, Claudio, et al.
Publicado: (2018)